Drug Metabolism Grants

American Society for Pharmacology and Experimental Therapeutics Division for Drug Metabolism Early Career Achievement Award

The ASPET Division for Drug Metabolism Early Career Achievement Award has been established to recognize excellent original research by early career investigators in the area of drug metabolism and disposition.

The award is presented biennially in odd-numbered years. The award consists of $1,000, a plaque, and complimentary registration plus travel expenses (to a maximum of $1,000) for the winner to attend the award ceremony at the annual meeting. The awardee will deliver a lecture at the annual meeting describing their relevant research accomplishments. The awardee will be invited to publish a review article on the subject matter of the award lecture in Drug Metabolism and Disposition.

Nominees for this award must have a doctoral degree (e.g. Ph.D., M.D., Pharm. D., D.V.M.) and must be within 15 years of having received their final degree, as of December 31 of the year of the award. There are no restrictions on institutional affiliation and a candidate need not be a member of ASPET. There is a requirement for two nominators, although more are acceptable. Nominators must be members of ASPET. An individual cannot nominate more than one candidate per award cycle.

Candidates who have made their research contributions in any sector (e.g. academia, industry, government) of the drug metabolism community may be nominated for the award. The primary criterion for the award is the level of excellence and originality of the research conducted by the candidate in the field of drug metabolism and disposition. Independence of thought, originality of approach, clarity of communication, and the impact of the work on the drug metabolism field are important considerations. Candidates shall not be judged in comparison with the work of more experienced investigators. Selection will be made by the Executive Committee of the Division for Drug Metabolism.

Nominations shall consist of the following components:

Two or more letters of nomination and support.
The five most significant published papers authored by the candidate. A detailed examination of these publications will form a primary basis for evaluation.
The candidate’s curriculum vitae and publication list.

All materials must be submitted as e-mail attachments in pdf format. Submit e-mail attachments to jane.nelson@aspet.org. Nominations for this award must be received no later than September 15, 2010.

ASPET Inquiries
9650 Rockville Pike
Bethesda, MD
20814-3995

Phone: (301) 634-7135
Fax: (301) 634-7061
Email: info@aspet.org

Bernard B. Brodie Award in Drug Metabolism

The B. B. Brodie Award in Drug Metabolism has been established to honor the fundamental contributions of Bernard B. Brodie in the field of drug metabolism and disposition. The Award is presented biennially in even years to recognize outstanding original research contributions in drug metabolism and disposition, particularly those having a major impact on future research in the field. The B. B. Brodie Award is sponsored by the Division for Drug Metabolism, and funds to support the award come from members’ contributions.

The award consists of a $2,000 honorarium, a commemorative medal, hotel and economy airfare to the award ceremony at the annual meeting. A lecture, delivered by the awardee at the annual meeting, describing appropriate research accomplishments and their future direction, will be published in Drug Metabolism and Disposition.

There are no restrictions on institutional affiliation, and a candidate need not be a member of the Society. The only restriction for the Award is that supporting research accomplishments must not be used to win any other major award. Only one nominator is necessary, although more are acceptable, and the nominators need not be members of ASPET. Selection of an awardee will be made biennially by the B.B. Brodie Award Committee, appointed by the President of ASPET with input from the Division for Drug Metabolism.

Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of:

Nominating letter and no more than five supporting letters detailing accomplishments of the nominee.
List of, and comments on, the outstanding papers.
Brief biographical sketch of the candidate.
Candidate’s curriculum vitae and bibliography.

Receipt date for nominations for the Bernard B. Brodie Award will be 5:00 pm on September 15, 2011 for an award to be presented at Experimental Biology ’12 in San Diego, CA.

ASPET Inquiries
9650 Rockville Pike
Bethesda, MD
20814-3995

Phone: (301) 634-7135
Fax: (301) 634-7061
Email: info@aspet.org

Julius Axelrod Award in Pharmacology

The Julius Axelrod Award in Pharmacology was established to honor the memory of the eminent American pharmacologist who shaped the fields of neuroscience, drug metabolism and biochemistry and who served as a mentor for numerous eminent pharmacologists around the world. The Julius Axelrod Award is presented annually for significant contributions to understanding the biochemical mechanisms underlying the pharmacological actions of drugs and for contributions to mentoring other pharmacologists.

The award consists of an honorarium of $5,000, a medal, hotel and economy airfare for the winner and spouse to the annual meeting. The formal presentation of this award and medal will be made at the annual meeting of ASPET. The recipient will be invited by the President of the Society to deliver the Julius Axelrod Lecture and organize the Julius Axelrod Symposium at the annual meeting a year hence. The recipient will also be invited by the Catecholamine Club to give a less formal presentation at its annual dinner meeting that year of the award.

There are no restrictions on nominees for this award. However, a nomination must be made by a member of the American Society for Pharmacology and Experimental Therapeutics (ASPET) or the Catecholamine Club. No member may nominate more than one candidate in a year, and no candidate may be nominated for more than one major ASPET award in any given year. The award shall be made on the basis of originality and uniqueness of accomplishments throughout a long career distinguished by sustained, significant contributions to research and mentoring in pharmacology. Selection of the recipient will be made by the Axelrod Award Committee, appointed by the President of ASPET and comprised of members of ASPET and the Catecholamine Club.

Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of:

1. Letter of nomination describing the research and mentoring contributions to pharmacology of the candidate that make him/her eligible for this Award, listing major contributions. Up to two additional letters of support would be welcome (need not be from ASPET members).
2. Brief biographical sketch of the candidate.
3. List of individuals mentored by the individual. Up to two letters from former trainees describing the quality of their training with the nominee and its impact on their careers would be welcome (need not be from ASPET members).
4. Candidate’s curriculum vitae and bibliography.

Receipt date for nominations for the Julius Axelrod Award will be 5:00 pm on September 15, 2010 for an award to be presented at Experimental Biology ’11 in Washington, DC.

American Society for Pharmacology and Experimental Therapeutics

ASPET Inquiries
9650 Rockville Pike
Bethesda, MD
20814-3995

Phone: (301) 634-7135
Fax: (301) 634-7061
Email: info@aspet.org

Epilepsy Research Award for Outstanding Contributions to the Pharmacology of Antiepileptic Drugs

(Deadline for submission of nominations is September 15, 2010)

The International League Against Epilepsy (ILAE) has sponsored an award of $2,000 and a Certification of Citation to be awarded by the American Society for Pharmacology and Experimental Therapeutics, for the purpose of recognizing and stimulating outstanding research leading to better clinical control of epileptic seizures. This research may include the basic screening and testing of new therapeutic agents, studies on mechanisms of action, metabolic disposition, pharmacokinetics, and clinical pharmacology studies.

The recipient will be selected by the Epilepsy Award Committee appointed by the President of ASPET, with representation of ILAE. Judgment will be based upon the significance of the candidate’s contribution to the treatment of epileptic seizures in human subjects. Selection will be free of restrictions on age, sex, nationality, institutional affiliation, or membership in scientific societies. The nominee must be actively engaged in research for which the Award is made, and primary emphasis will be placed upon work accomplished in the five-year period prior to each Award.

Nominations for the Award may be submitted by members of any recognized scientific association, domestic or foreign.

Nominations shall be submitted electronically to jane.nelson@aspet.org and shall consist of:

1. A summary describing the nominee’s major achievements.
2. Candidate’s curriculum vitae and bibliography.
3. Six of the nominee’s most significant papers, published or accepted for publication (provided as PDFs or as hyperlinks to the article). Submit each manuscript PDF as a separate attachment.

The biennial award shall be presented to the recipient at the annual meeting of ASPET. Hotel and economy airfare to the annual meeting for the recipient and his/her spouse will be provided.

Receipt date for nominations for the Epilepsy Research Award will be 5:00 pm on September 15, 2010 for an award to be presented at Experimental Biology ’11 in Washington, DC.

American Society for Pharmacology and Experimental Therapeutics
9650 Rockville Pike, Bethesda, MD 20814-3995
(301) 634-7060 info@aspet.org